UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equinix
EQIX
|
+$1.32B |
| 2 |
Digital Realty Trust
DLR
|
+$931M |
| 3 |
Western Digital
WDC
|
+$895M |
| 4 |
Simon Property Group
SPG
|
+$736M |
| 5 |
Realty Income
O
|
+$643M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$1.73B |
| 2 |
Eaton
ETN
|
+$1.21B |
| 3 |
Seagate
STX
|
+$1.1B |
| 4 |
Trane Technologies
TT
|
+$1.02B |
| 5 |
Accenture
ACN
|
+$1.01B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 40.05% |
| 2 | Financials | 11.12% |
| 3 | Healthcare | 9.54% |
| 4 | Consumer Discretionary | 9.09% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Equity Bancshares
EQBK
$1.03B
| $1.03M | ﹤0.01% |
21,008
| – | – |
|
2302
iShares MSCI Canada ETF
EWC
$6.87B
| $1.02M | ﹤0.01% |
17,742
-158,504
| -90% | -$9.17M |
|
|
AGNT
2303
AGNT Inc
AGNT
$665M
| $1.02M | ﹤0.01% |
187,921
-12,265
| -6% | -$67.6K |
|
|
GRDN
2304
Guardian Pharmacy Services
GRDN
$2.69B
| $1.02M | ﹤0.01% |
24,249
+1,464
| +6% | +$56.7K |
|
2305
Schwab US Aggregate Bond ETF
SCHZ
$10.7B
| $1.01M | ﹤0.01% |
43,585
-1,694
| -4% | -$39.2K |
|
2306
ASP Isotopes
ASPI
$647M
| $1M | ﹤0.01% |
161,219
+48,743
| +43% | +$287K |
|
|
INFQ
2307
Infleqtion Inc
INFQ
$3.08B
| $1M | ﹤0.01% |
+75,122
| New | +$1.03M |
|
2308
First Trust Exchange-Traded Fund IV First Trust Tactical High Yield ETF
HYLS
$1.63B
| $997K | ﹤0.01% |
24,515
| – | – |
|
2309
BlackSky Technology
BKSY
$904M
| $994K | ﹤0.01% |
35,589
-3,805
| -10% | -$137K |
|
2310
Sana Biotechnology
SANA
$1.03B
| $993K | ﹤0.01% |
284,472
+52,766
| +23% | +$170K |
|
|
BDN
2311
Brandywine Realty Trust
BDN
$527M
| $989K | ﹤0.01% |
312,025
-197,347
| -39% | -$593K |
|
2312
Amcor
AMCR
$20.5B
| $988K | ﹤0.01% |
22,799
-2,526,792
| -99% | -$100M |
|
2313
Schwab US Large-Cap Growth ETF
SCHG
$62.4B
| $988K | ﹤0.01% |
29,198
-78,549
| -73% | -$2.6M |
|
|
GOOD
2314
Gladstone Commercial Corp
GOOD
$634M
| $987K | ﹤0.01% |
80,282
+79,618
| +11,991% | +$992K |
|
2315
Five Star Bancorp
FSBC
$1.14B
| $984K | ﹤0.01% |
20,218
-669
| -3% | -$28.2K |
|
2316
EverQuote
EVER
$879M
| $981K | ﹤0.01% |
41,237
+4,504
| +12% | +$82.5K |
|
|
GLIBK
2317
Liberty Capital Corp Series C GCI Group Common Stock
GLIBK
$1.03B
| $976K | ﹤0.01% |
45,252
-26,736
| -37% | -$751K |
|
2318
SI-BONE Inc
SIBN
$835M
| $975K | ﹤0.01% |
59,736
-27,538
| -32% | -$393K |
|
2319
Invesco S&P MidCap Momentum ETF
XMMO
$7.44B
| $972K | ﹤0.01% |
5,715
-736
| -11% | -$120K |
|
2320
State Street SPDR S&P Dividend ETF
SDY
$21.6B
| $971K | ﹤0.01% |
6,382
-1,010
| -14% | -$150K |
|
2321
Business First Bancshares
BFST
$1.02B
| $971K | ﹤0.01% |
31,600
+766
| +2% | +$21.6K |
|
2322
Butterfly Network
BFLY
$2B
| $970K | ﹤0.01% |
115,220
-212,880
| -65% | -$1.1M |
|
|
DRD
2323
DRDGold
DRD
$2.43B
| $966K | ﹤0.01% |
+45,373
| New | +$1.23M |
|
|
ZBIO
2324
Zenas BioPharma
ZBIO
$2.15B
| $959K | ﹤0.01% |
37,790
+22,267
| +143% | +$443K |
|
2325
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.1B
| $952K | ﹤0.01% |
11,566
-542
| -4% | -$45.4K |
|
Similar funds
UBS AM's Q2 2026 Portfolio in Review
As of Q2 2026, UBS AM held 3,886 positions worth $550B, up 14% from $481B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
UBS AM's Q2 2026 filing shows 45 new, 996 increased, 1,636 reduced and 163 closed positions. Its largest new stake was Honeywell Aerospace: 1,676,062 shares worth $371M. The largest sale was Linde, an estimated $1.73B.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.
- UBS AM's largest Q2 2026 buy was Honeywell Aerospace: 1,676,062 shares worth $371M.
- UBS AM added most to Equinix in Q2 2026, an estimated $1.32B increase.
- UBS AM's biggest Q2 2026 reduction was Linde, cutting an estimated $1.73B.
- UBS AM fully exited Hologic in Q2 2026, selling an estimated $174M.
- UBS AM's ten largest holdings make up 33% of its $550B portfolio in Q2 2026.
- UBS AM opened 45 new positions and closed 163 in Q2 2026.
- UBS AM's portfolio value rose 14% quarter-over-quarter to $550B.
Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.